Stock vs Stock Comparison

Johnson Controls International plc vs Arcosa, Inc.

JCI wins the Tale of the Tape 5–4.

JCI$146.96
ACA

🏆 Tale of the Tape

54
JCIACA
14.0%Profitability (Net Margin)7.2%
41.0xValuation (P/E)28.3x
6.4%Efficiency (ROIC)6.2%
6/9Health (Piotroski F)8/9
2.9Safety (Altman Z)
2.8%Growth (Rev YoY)12.2%
2.25Risk (Sharpe 1Y)
1.93xBalance Sheet (D/E)0.89x
1.01%FCF Yield

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricJCIACA
Market Cap$81.8B$5.9B
P/E Ratio41.0x28.3x
Forward P/E23.5x22.4x
P/B6.05x2.23x
Dividend Yield1.19%0.17%
Beta1.390.96

Quantitative Metrics

MetricJCIACA
DCF Fair Value$99.96
DCF Upside
Piotroski F6/98/9
Altman Z2.88
Beneish M-2.28-2.48
FCF Yield1.01%
Net Debt/EBITDA2.7x2.3x
ROIC6.4%6.2%
WACC12.6%
ROIC – WACC-6.1pp
Gross Margin36.4%22.4%
Net Margin14.0%7.2%
Rev Growth YoY2.8%12.2%
Sharpe (1Y)2.25
Max Drawdown 3Y-30.9%
FCF Payout Ratio101%6%

JCI Price

Loading chart...

ACA Price

Loading chart...

ETF Exposure

JCI found in:

XHB3.56%
XLI1.56%
VIS1.27%
VOE0.79%
VFMV0.57%
VFMO0.54%
VO0.45%
VYM0.37%
VTV0.35%
VONV0.27%
ONEO0.25%
MGV0.22%
ESGV0.16%
SPYG0.16%
VOO0.14%
VONE0.14%
VTI0.13%
SPY0.13%
SPLG0.13%
SPTM0.12%
SPYV0.10%
VT0.08%
QUS0.05%

ACA found in:

SLYG0.45%
SPSM0.35%
SLYV0.25%
VTWO0.18%
VFMO0.15%
VBR0.14%
VGK0.12%
VYMI0.10%
VIS0.09%
SPDW0.08%
VB0.08%
VXF0.08%
VEA0.06%
VSGX0.06%
CWI0.05%
VEU0.05%
VXUS0.04%
SPTM0.01%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

JCI vs ACA: Head-to-Head Analysis

Johnson Controls International plc (JCI) and Arcosa, Inc. (ACA) represent two companies in the Industrials sector. In our quantitative Tale of the Tape scoring, JCI leads 5–4 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, JCI generates a return on invested capital (ROIC) of 6.4% compared to ACA's 6.2%. This suggests JCI is more effective at deploying capital to generate shareholder returns.

JCI appears in 23 ETFs tracked by SecuritiesDB, while ACA appears in 18 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, JCI or ACA?

Our quantitative analysis compares JCI and ACA across nine fundamental dimensions. JCI wins the Tale of the Tape 5–4. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are JCI and ACA correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.